ReWalk Robotics Stock Quote LFWD - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

4.75

Bid

4.68

Ask

4.87

Volume

0.00 Day's Range 0.00

3.90 52 Week Range 7.84

Market Cap

8.922M

Previous Close

4.75

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

188,513

Shares Outstanding

8,497,162

Dividend Yield

PE Ratio

-0.40

Earnings Per Share (EPS)

-2.6

Revenue

13.85M

Net Profit

-22.13M

ReWalk Robotics Ltd is an Israel based medical device company. It is engaged in designing, developing and commercializing the Rewalk systems which are exoskeletons allowing wheelchair-bound individuals to stand and walk once again. The ReWalk systems allow the users to sit, stand, walk, turn and hav... ReWalk Robotics Ltd is an Israel based medical device company. It is engaged in designing, developing and commercializing the Rewalk systems which are exoskeletons allowing wheelchair-bound individuals to stand and walk once again. The ReWalk systems allow the users to sit, stand, walk, turn and have the ability to climb and descend stairs. It offers two systems, ReWalk Personal which is designed for every day and all day use by individuals at home and in their communities and is custom-fit for each user; and ReWalk Rehabilitation which is designed for the clinical rehabilitation environment where it provides the user with valuable training exercise and therapy. The company generates maximum revenue from the United States and Europe. Show more

Sector

Ortho,prosth,surg Appl,suply

Industry

Ortho,prosth,surg Appl,suply

Website

www.rewalk.com

Headquarters

Yokneam, North, Isr

Founded

1970

ReWalk Robotics Ltd is listed in the Ortho,prosth,surg Appl,suply sector of the NASDAQ with ticker LFWD. The last closing price for ReWalk Robotics was $4.75. Over the last year, ReWalk Robotics shares have traded in a share price range of $ 3.90 to $ 7.84.

ReWalk Robotics currently has 8,497,162 shares outstanding. The market capitalization of ReWalk Robotics is $8.92 million. ReWalk Robotics has a price to earnings ratio (PE ratio) of -0.40.

Lifeward Announces the Appointment of Mike Swinford to its Board of Directors

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, April 19, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (DBA Lifeward™) (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global market lead...

Medicare Revises 2024 Fee Schedule to Include Payment Rate for the ReWalk Personal Exoskeleton

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, April 12, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (DBA Lifeward™), (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global market leader...

Lifeward CEO Issues Open Letter to Shareholders on Progress to Finalize Exoskeleton Medicare Payment Rate

Collaboration with CMS on final payment rate focuses on commercial transaction values for the latest generation of ReWalk Exoskeleton CMS indicates that recently issued fee schedule which omitted...

VA STAND Act introduced in the United States Senate

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, March 22, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (DBA Lifeward™), (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global market leader...

Lifeward Announces Reverse Share Split

Reverse split initiated to regain compliance with Nasdaq listing requirements Financial guidance for 2024 and profitability target for 2026 on existing capital remain unchanged MARLBOROUGH, Mass...

ReStore Exo-Suit Publications Demonstrate Improved Walking Outcomes Versus Conventional Stroke Therapy

Randomized clinical trial demonstrates significant improvements in walking ability for patients receiving therapy with the ReStore Exo-Suit as compared to a matched control group receiving...

Lifeward announces the Centers for Medicare & Medicaid Services (“CMS”) is deferring its final decision on the payment rate for personal exoskeletons so that more recent claims information on the current, more advanced ReWalk Personal Exoskeleton may b

The decision was communicated through CMS’ bi-annual Healthcare Common Procedure Coding System (“HCPCS”) coding memorandum released yesterday; payment amount determination for ReWalk Personal...

Lifeward Reports Fourth Quarter and Full Year 2023 Financial Results

Highest quarterly and annual revenue in the history of LifewardCommercial and operational integration complete; synergiesexpected to yield $3 million in annual net savings MARLBOROUGH, Mass. and...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.03	0.635593220339	4.72	4.88	4.62	17127	4.75021008	CS
4	-0.53	-10.0378787879	5.28	6	4.5	58180	5.1804176	CS
12	-1.697	-26.3223204591	6.447	7.7	3.9	188513	5.51911534	CS
26	-2.25	-32.1428571429	7	7.84	3.9	188417	5.66233407	CS
52	-2.25	-32.1428571429	7	7.84	3.9	188417	5.66233407	CS
156	-2.25	-32.1428571429	7	7.84	3.9	188417	5.66233407	CS
260	-2.25	-32.1428571429	7	7.84	3.9	188417	5.66233407	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AAGRAfrican Agriculture Holdings Inc	$ 0.3798 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 60.83 (0.00%)	0
AADIAadi Bioscience Inc	$ 1.94 (0.00%)	0
AACIArmada Acquisition Corporation I	$ 11.63 (0.00%)	0
AACGATA Creativity Global	$ 0.8999 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	$ 0.3798 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 60.83 (0.00%)	0
AADIAadi Bioscience Inc	$ 1.94 (0.00%)	0
AACIArmada Acquisition Corporation I	$ 11.63 (0.00%)	0
AACGATA Creativity Global	$ 0.8999 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	$ 0.3798 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 60.83 (0.00%)	0
AADIAadi Bioscience Inc	$ 1.94 (0.00%)	0
AACIArmada Acquisition Corporation I	$ 11.63 (0.00%)	0
AACGATA Creativity Global	$ 0.8999 (0.00%)	0